H.C. Wainwright reiterates UroGen Pharma stock rating on NDA filing — See source for full details.
$URGN
Price history, market instrument context, member research, and related headlines in one place.
URGN key statistics
NasdaqGMUSD
52-week range
$16.3759%$50.81
Latest session $36.27–$38.37UroGen Pharma Ltd. (URGN) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $36.61, up $0.03 (0.08%) from the previous close of $36.58. It has traded between $36.27 and $38.37 in the latest session. Over the past year it has ranged from $16.37 to $50.81, leaving it around the middle of its 52-week range (59%). Reported volume for the session was 626.4K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
UroGen Pharma secures option deal with IntraGel for cancer tech — See source for full details.
UroGen Pharma GAAP EPS of -$0.28 in-line, revenue of $72.5M beats by $8.96M; updates FY outlook — See source for full details.
UroGen Pharma faces earnings test as Zusduri growth accelerates — See source for full details.
Loading $URGN research…